We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Cardiac Biomarker Assesses Heart Failure Prognosis

By LabMedica International staff writers
Posted on 02 Feb 2011
The levels of cardiac biomarkers in blood plasma predict the outcome for ambulatory outpatients with chronic heart failure and they more effectively risk-stratify such patients.

An assay to measure the amount of soluble growth stimulation expressed gene 2 protein (ST2) has been used to identify heart failure patients who are significantly more likely to have a heart transplant or to die during the three-year follow-up period.

In a multicenter cohort study, 1,141 heart failure patients were recruited from three tertiary-care centers, and were followed for a median of 2.8 years. More...
ST2 levels were measured at baseline from a blood sample taken at the enrollment of each patient into the study. The investigators conducted statistical analyses to predict outcomes by examining clinical presentation as well as the cardiac biomarkers ST2 and N-terminal brain natriuretic peptide (NT-proBNP).

The test used was the Presage ST2 Assay (Critical Diagnostics, San Diego, CA, USA). There were 267 (23% of patients) adverse events over the period, defined as the combined endpoint of death or cardiac transplantation. Patients in the highest ST2 tertile with levels above 36.3 ng/mL, had a markedly increased risk of adverse outcomes compared to the lowest tertile whose ST2 levels were equal to or less than 22.3 ng/mL. The unadjusted hazard ratio (HR) of 3.2 remained significant after multivariable adjustment; adjusted HR equaled 1.9. With each doubling of ST2, there was a 40% to 50% increased risk of death or cardiac transplantation in fully adjusted models.

Soluble ST2 reflects activity of an interleukin (IL-33) dependent cardioprotective signaling axis and is a diagnostic and prognostic marker in acute heart failure. ST2 signals the presence of adverse cardiac remodeling and fibrosis, which occurs in response to myocardial infarction (MI), ischemia, or worsening heart failure. Remodeling and fibrosis can also contribute to the development of future adverse events, such as secondary MI or sudden cardiac death, and to progression of heart failure.

Patrick A. Arensdorf, B.A., M.B.A., CEO of Critical Diagnostics, said, "The study found that more than one in seven chronic heart failure patients can be more appropriately risk-stratified when using ST2 and NT-proBNP in addition to the Seattle Heart Failure Model. By using the Presage ST2 Assay, clinicians may be able to target heart failure therapy more appropriately.” The study was published as an advance e-publication of the January 19, 2010 edition of Circulation: Heart Failure.

Related Links:
Critical Diagnostics



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.